Re-Appointment of Mr. Ashish Ravi Puravankara, Managing Director of the Company
MANAGEMENT
● No Immediate Change
LOW RISK
📅 Filed on BSE: 20 Mar 2026, 01:45 PM IST · BSE ID: 84a104e7-dc8d-47ca-b193-8a815f8fd0bd
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board member and top executive keeps his job for another five years, with a pay raise approved by shareholders.
🤖 AI Summary
- Ashish Ravi Puravankara re-appointed Managing Director for 5 years from April 1, 2026, to March 31, 2031
- Remuneration enhanced for 3-year period April 1, 2026, to March 31, 2029
- Shareholder approval granted via Postal Ballot dated March 19, 2026, based on Board February 12 recommendation
- Company operates 9 cities: Bengaluru, Mumbai, Pune, Goa, Hyderabad, Chennai, Kochi, Coimbatore, Mangaluru
🔢 Key Numbers — exact figures from BSE filing, not rounded
MD re-appointment term
5 years, April 1, 2026, to March 31, 2031
Enhanced remuneration period
3 years, April 1, 2026, to March 31, 2029
Operating cities
9 cities (Bengaluru, Mumbai, Pune, Goa, Hyderabad, Chennai, Kochi, Coimbatore, Mangaluru)
🏢 How This Affects the Company
MD continuity ensures sustained strategic direction across real estate portfolio spanning nine Indian cities and newly entered Mumbai redevelopment market.
Enhanced remuneration increases MD compensation outflow for the 3-year period ending March 31, 2029.
Leadership continuity under a 5-year mandate provides operational stability and oversight of construction quality, innovation deployment, and project completion across residential and commercial segments.
👥 What This Means For Shareholders
✅
Action Required
No action required. Shareholder approval already obtained via Postal Ballot dated March 19, 2026.
👤
Who Is Affected
All shareholders hold equity in a company now committed to MD leadership continuity through March 31, 2031. Enhanced MD remuneration reduces distributable cash for 3 years ending March 2029.
🔍
Management Signal
Board and shareholders backing MD's strategic vision confirms confidence in current leadership's execution of multi-city residential-commercial pipeline.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q4 FY26 results announcement — track project completions and revenue recognition trends across nine-city portfolio
Annual report FY26 filing — confirm enhanced MD remuneration disclosure and compensation details for 3-year period
Mumbai redevelopment project launches — monitor new project announcements under confirmed MD leadership through 2031
LOW RISK
Management continuity reduces leadership transition risk. No governance flags or adverse terms disclosed in re-appointment filing.
💡 Investor Takeaway
MD Ashish Ravi Puravankara secures 5-year re-appointment from April 2026 with enhanced remuneration through March 2029. Continuity confirmed across nine-city real estate portfolio including newly entered Mumbai redevelopment market.
⚖️ Strengths & Concerns
✅ Positives
- MD continuity for 5-year term ensures strategic stability across nine-city portfolio and emerging Mumbai redevelopment operations.
- Enhanced remuneration likely aligns MD incentives with company growth objectives across multiple geographies and segments.